Early clinical deterioration in incident pulmonary arterial hypertension (PAH) remains a major challenge despite contemporary combination therapy. Appropriate identification of patients at high risk of early life-threatening deterioration after treatment initiation (i.e. early treatment failure, ETF) may enable t...
G. Savonitto, P. Gentile, M. Toma et al.· European Heart Journal· 0 citations
Late gadolinium enhancement (LGE) is a robust prognostic marker in non-ischemic cardiomyopathies, yet its longitudinal evolution and clinical implications remain incompletely defined. We aimed to quantify LGE progression over time and evaluate its determinants and prognostic value in dilated cardiomyopathy (DCM)...
F. Bonanni, G. Todiere, I. Bellisario et al.· European Heart Journal· 0 citations
Both invasive hemodynamic and device-based remote monitoring are economically advantageous for heart failure management across multiple healthcare systems, and these findings align with recent national health-technology guidance recommending both technologies.
A. Capodici, Francesca Noci, M. Coceani et al.· European Heart Journal - Qua...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.